Second Line Capital »

GSK shares owned by Second Line Capital

Quarter-by-quarter ownership of GSK (GSK) shares owned by Second Line Capital from 13F filings

Historical chart of Second Line Capital investment in GSK

Tip: Access up to 7 years of quarterly data

All positions including GSK held by Second Line Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GSK by Second Line Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $245k 6.0k 41.19

More positions owned by Second Line Capital

Etf Ser Solutions Aptus Collrd Inv (ACIO)
Etf Ser Solutions Aptus Defined (DRSK)
Etf Ser Solutions Aptus Int Enh Yl (IDUB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Etf Ser Solutions Aptus Drawdown (ADME)
Etf Ser Solutions Aptus Enhanced (JUCY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Etf Ser Solutions Aptus Large Cap (DUBS)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Meta Platforms Cl A (META)
Apple (AAPL)

View all positions for Second Line Capital

Top funds holding GSK

Dodge & Cox
JTC Employer Solutions Trustee
Fisher Investments
PRIMECAP Management Company
Morgan Stanley
T. Rowe Price Associates
Royal Bank of Canada
State Street Corporation
Mondrian Investment Partners
Goldman Sachs Group
Acadian Asset Management
Provident Trust
Arrowstreet Capital, Limited Partnership
Hsbc Holdings
Hotchkis and Wiley Capital Management

View all funds holding GSK